Cancer Topics

The On-Topic Netowork

Cancer > Immunotherapy


Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy

The following information is about Immunotherapy.

Immunotherapy Defined

Treatment to stimulate or restore the ability of the immune system to fight infections and other diseases. Also used to lessen side effects that may be caused by some cancer treatments. Also known as biological therapy, biotherapy, or biological response modifier (BRM) therapy.

This definition is in context to Cancer. See more contextual defintions for Immunotherapy.


ImmunoCellular Therapeutics Announces Filing of Patent Application for a Novel Cancer Stem Cell Vaccine Technology

Published October 9, 2008, 6:00 am, Business Wire via Yahoo! Finance

LOS ANGELES----ImmunoCellular Therapeutics, Ltd. , a biotechnology company, announced the filing of a provisional U.S. patent application relating to its novel vaccine technology targeting cancer stem cells.

Full Story


CEL-SCI Enters Agreement With National Institutes Of Health Clinical Center To Determine The Molecular Basis Of ...

Published October 8, 2008, 3:06 am, Medical News Today

CEL-SCI Corporation (NYSE: CVM) announced that it has entered into a Material Transfer Agreement (MTA) with the National Institutes of Health Clinical Center (NIHCC) and the laboratory of Dr. Francesco M. Marincola, M.D., to investigate the molecular basis of changes to the tumor microenvironment caused by CEL-SCI's cancer drug Multikine. Dr.

Full Story


Biovest Announces BiovaxID(R) Anti-Cancer Vaccine Prolongs Cancer-Free Survival by 44%

Published October 7, 2008, 8:15 am, Business Wire via Yahoo! Finance

TAMPA, Fla.----Biovest International, Inc. , a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. , today provided an update on its personalized, anti-cancer vaccine, BiovaxID®, including reporting clinically and statistically significant data from its randomized controlled pivotal Phase 3 Fast-Tracked clinical trial for the treatment of indolent follicular non-Hodgkin's lymphoma, ...

Full Story


CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of ...

Published October 7, 2008, 7:34 am, PR Newswire via Yahoo! Finance

CEL-SCI Corporation announced today that it has entered into a Material Transfer Agreement with the National Institutes of Health Clinical Center and the laboratory of Dr. Francesco M.

Full Story


Advaxis Incorporated Collaborates on Groundbreaking Listeria Moncoytogenes Immunotherapy Research Discovery

Published October 7, 2008, 7:00 am, Business Wire via Yahoo! Finance

NORTH BRUNSWICK, N.J.----Advaxis Incorporated , a developmental biotechnology company, and a team of investigators from the University of Pennsylvania and the Hilman Cancer Center in Pittsburgh recently published a research paper in the October 2008 edition of Cancer Research demonstrating the tumor eliminating properties of a live Listeria monocytogenes vaccine in a variety of different of ...

Full Story


Are you looking for additional Cancer > Immunotherapy news? Try our new "Immunotherapy News Focus" area.

Off-site Immunotherapy Links, User Submitted

The following links have been collected through user bookmark submission in the Immunotherapy category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Mon Oct 6

Mon Sep 15

Sun Sep 7

Sat Sep 6

Thu Aug 28

Wed Aug 27

Sat Aug 23

Wed Aug 20

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Immunotherapy. If you would like to find related tags we recommend Tag Patterns > Immunotherapy

Off-site Immunotherapy Research Links

If you still need additional information on Immunotherapy then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Cancer

If you know the Cancer Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a